(Q34141753)

31 July 2017

title

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study (English)

1 reference

31 July 2017

0 references

A J Swerdlow

1

0 references

author name string

C D Higgins

series ordinal

2

1 reference

31 July 2017

P Adlard

series ordinal

3

1 reference

31 July 2017

M A Preece

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

360

1 reference

31 July 2017

issue

9329

1 reference

31 July 2017

page(s)

273-277

1 reference

Treatment of a pituitary dwarf with human growth hormone

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Safety of growth hormone after treatment of a childhood malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Growth hormone treatment induces mammary gland hyperplasia in aging primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Acromegaly and gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Acromegaly, colonic polyps and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Risk of leukemia after treatment with pituitary growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Risk of leukemia in children treated with human growth hormone: review and reanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

Colorectal neoplasia in acromegaly: the reported increased prevalence is overestimated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

High-risk colorectal adenomas and serum insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909519-3

7 January 2021

10.1016/S0140-6736(02)09519-3

Identifiers

DOI

1 reference

31 July 2017

1 reference